-
Disappointing Drug News Sends Biogen And XOMA Shares Down
Wednesday, July 22, 2015 - 10:34am | 560Read More...Shares of Biogen Inc (NASDAQ: BIIB) were trading lower by more than 3 percent Wednesday morning after the company reported mixed results in a Phase 1 Alzheimer's study in which a 6MG dose failed to significantly slow mental decline. "We are encouraged by these new results, which...
-
RBC Says Biogen Can Move 10% After BIIB-037 Data Is Revealed
Friday, July 10, 2015 - 12:04pm | 317Read More...Biogen Inc (NASDAQ: BIIB) is down 3 percent on Friday after commentary from Cowen. Analyst Eric Schmidt suggested investors not play the company's upcoming AAIC data reveal centered on Aducanumab, scheduled for July 22, due to a lack of conviction. It didn't take long for RBC's...
-
Large-Cap Biotechs Poised For Second-Half Rally, RBC Says
Thursday, July 9, 2015 - 9:21am | 318Read More...RBC Capital Markets Analyst Michael Yee said in a new research note that the recent 5 to 6 percent pullback in large-cap biotech will provide a good opportunity heading into what they expect will be "mostly in-line to better" earnings. On a macro basis, Yee reiterated the firm's...
-
Big Biotech Stocks See Declining Short Interest
Friday, June 12, 2015 - 7:57am | 890Read More...While short interest moves in most of the leading biotechs and emerging pharmaceuticals were mild between the May 15 and May 29 settlement dates, short sellers fled from some of the biggest players in the field. Biogen Inc (NASDAQ: BIIB), Celgene Corporation (NASDAQ: CELG) and Gilead Sciences, Inc...
-
Highlights From ISIS Pharmaceuticals At Goldman Sachs Healthcare Conference
Thursday, June 11, 2015 - 1:36pm | 541Read More...ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) presented at Goldman Sachs' annual Global Healthcare Conference on Wednesday. VP of Corporate Communications and Investor Relations D. Wade Walke discussed the drug maker's advanced technology, business model, and current pipeline. Antisense...
-
3 Biotech Stocks See Growing Short Interest
Wednesday, May 13, 2015 - 9:40am | 887Read More...While short interest in most of the leading biotechs and emerging pharmaceuticals shrank between the April 15 and April 30 settlement dates, three stocks bucked that trend. Biogen Inc (NASDAQ: BIIB), Illumina, Inc. (NASDAQ: ILMN) and Juno Therapeutics Inc (NASDAQ: JUNO) saw the number of their...
-
Biogen Or Bluebird: Which Will Lead In SCD?
Thursday, April 30, 2015 - 12:42pm | 428Read More...On April 29, Joshua Schimmer of Piper Jaffray released a report highlighting several biopharmaceutical companies tackling Sickle Cell Disease, or SCD. The hereditary blood disorder is recognized by abnormal hemoglobin in the blood. Schimmer believes that to cure SCD with gene therapy, only...
-
Expert: Biogen Is Closing In On The 'Holy Grail' For Biotech Stocks
Thursday, April 30, 2015 - 12:01pm | 141Read More...In this week's episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights. In the episode, Joe discusses Biogen Inc (NASDAQ: BIIB)'s new drug, which could be the holy grail for biotech stocks. Leigh and Joe also chat about a...
-
Nomura's Takeways From Biogen Idec's Analyst Meeting
Friday, January 16, 2015 - 12:06pm | 205Read More...Ian Somaiya on Friday commented in a note that Biogen Idec Inc's (NASDAQ: BIIB) management team during a recent analyst meeting pointed to potential reasons for the recent slowdown in Ecfidera uptake. According to Somaiya, Biogen noted: "1) The burst of active switching caused by...
-
Markets Close Higher Following Strong November Auto Sales
Tuesday, December 2, 2014 - 5:46pm | 885Read More...U.S. stocks were mostly higher as investors and traders focused on U.S. November automobile sales, rather than Cyber Monday sales. U.S. automobile sales rose 4.6 percent in November to 1.3 million, higher than the 1.27 million analysts were expecting. Cyber Monday sales were expected to grow...
-
Markets Reverse Early Morning Gains Following Canadian Shooting
Wednesday, October 22, 2014 - 4:43pm | 1767Read More...U.S. stocks reversed early morning gains following a fatal shooting of a Canadian soldier in the nation's capital and a subsequent gunfight inside Canada's Parliament. Declining oil prices was also cited as a factor for the poor performance in equities on Wednesday following the release...
-
Markets Mostly Higher As Earnings Season Continues To Impress
Wednesday, July 23, 2014 - 4:55pm | 2953Read More...U.S. stocks were mostly higher as investors and traders continue to weigh in on earnings from large-cap companies like Apple, Microsoft, Facebook, and momentum high-flyers like Chipotle Mexican Grill and Intuitive Surgical. Despite geopolitical concerns, the S&P 500 managed to close at a...
-
Market Wrap For May 29: Investors Welcome Another Record High For The S&P 500
Thursday, May 29, 2014 - 4:41pm | 2596Read More...U.S. stocks gained on Thursday despite the Commerce Department reporting that U.S. gross domestic product declined at a one percent annualized rate in the quarter. Analysts were expecting GDP to decline 0.4 percent. Pending home sales were below expectations but investors may have shrugged off...
-
Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week
Monday, April 28, 2014 - 4:34pm | 2080Read More...U.S. stocks ended the day mostly positive in a volatile trading session as the Nasdaq rebounded from a one percent decline, finishing the day almost flat. The Dow traded higher by as much as 138 points but still ended the day modestly higher as Pfizer's massive $100 billion takeover plans gave...
-
Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns
Thursday, April 24, 2014 - 4:41pm | 3104Read More...U.S. stocks inched higher as Apple's strong earnings reported on Wednesday proved to be not enough to ease fears over an escalating tension between Russia and Ukraine. Reports surfaced of escalated troop movements in Ukraine while Russia began military drills near the Ukraine border. After...
